
Kolon Life Science turns profit in chemicals biz, eyes '2nd Invossa'
After nearly two years of losses, Kolon Life Science has turned its fortunes around. The company attributes the turnaround to solid business performance in the chemical division since CEO Kim took office. In addition, the company has reorganized its R& …